Anti-CASPR2 Antibody Measurement by Immunoassay (CSF)
This test detects antibodies against the CASPR2 protein in cerebrospinal fluid (CSF). These antibodies are linked to certain autoimmune neurological conditions.
["This test helps diagnose or evaluate conditions like limbic encephalitis or other autoimmune-related neurological symptoms."]
Key facts at a glance
- LOINC
- 109460-6
- Short code
- CASPR2CSF
- Synonyms
- CASPR2 Ab Msmt CSF
- Category
- chemistry
- Sample
- csf
- Container
- Sterile, screw-cap polypropylene collection tube (tube #3 or #4 of standard lumbar puncture collection series)
- Units
- N/A
- Ref low
- 0
- Ref high
- 1
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- Cell-based indirect immunofluorescence assay (CBA-IFA) or fixed cell-based assay; may also be performed by enzyme-linked immunosorbent assay (ELISA) or immunohistochemistry (IHC)
- CPT
- 86255
- SNOMED
- 407660008
- Specimen volume
- 1-2 mL of cerebrospinal fluid; minimum 0.5 mL required for analysis
- Stability
- Room temperature: 2 hours; Refrigerated (2-8°C): 7 days; Frozen (-20°C or lower): up to 6 months. Avoid repeated freeze-thaw cycles. Ship on dry ice if referring to another laboratory.
- Hemolysis max
- 200
- TAT
- 72–336 hours
- Order
- routine
Why This Test Is Done
Your doctor may order this test if you have symptoms such as memory problems, confusion, seizures, or unexplained movement disorders. These symptoms can sometimes be caused by an autoimmune response targeting the nervous system. The test checks for specific antibodies in your CSF that may indicate an underlying condition like CASPR2-associated limbic encephalitis.
What to Expect Before the Test
No special preparation is needed. The test involves a lumbar puncture (spinal tap), where a small amount of CSF is collected from your lower back. This procedure is usually done in a hospital or clinic setting and may cause mild discomfort.
What the Results Mean
Positive results for CASPR2 antibodies in CSF can support a diagnosis of autoimmune neurological disorders. However, results alone may not confirm a diagnosis; they are often used alongside clinical findings and other tests.
Possible Conditions Linked to Positive Results
Positive antibody levels may be associated with conditions such as limbic encephalitis (a type of brain inflammation), paraneoplastic neurological syndromes (caused by cancer), or other autoimmune-related neurological diseases.
Reference range
Negative: titer <1:10 (cell-based assay); <1:100 may be considered borderline. Positive results are reported as endpoint titers (e.g., 1:10, 1:32, 1:100, 1:320, 1:1000). Reference values may vary by performing laboratory and assay methodology.N/A
No fasting required. Patient should be informed about the lumbar puncture procedure, including risks of headache, infection, and bleeding. Informed consent is required prior to CSF collection.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Clinical Significance
Short name
CSF Anti-CASPR2 Antibody
Frequently asked questions
What does it mean if my test results are positive?
Can this test be used to diagnose all neurological disorders?
How often will I need this test?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy